Daniel Lippis J., CVP, TAVR at Edwards Lifesciences Corp, Sells Shares Worth $54,169

Edwards Lifesciences Corp (EW) disclosed that Daniel Lippis J., who holds the position of CVP, TAVR at the company, was involved in selling 619 shares, per a Form 4 filing with the SEC.

The transaction was executed at a price of $87.51 per share, for a total value of approximately $54,169.

Company insiders are required to disclose changes in their stock ownership to the SEC on Form 4, typically within two business days of the trade.

Sales by insiders often reflect routine portfolio management or pre-scheduled trading plans rather than a view on the company's prospects.